1) transdermal release
透皮释放度
1.
Study on preparation of complex scutellariae baicalensis cataplasm and transdermal release;
复方黄芩巴布剂的制备及透皮释放度测定
2) release rate and percutaneous rate
释放度和透皮率
3) release test and percutaneous test
释放度和离体透皮试验
4) transcutaneous permeation in vitro
体外透皮释放
1.
The EB transcutaneous permeation in vitro was studied with Franz diffusion one cell apparatus.
文中采用高效液相色谱法测定苯甲酸雌二醇贴片中苯甲酸雌二醇 (EB)的含量和体外透皮释放量。
5) transdermal delivery
透皮释药
1.
Study on transdermal delivery of transfersomes loading with Amlodipine Besylate in vitro;
载氨氯地平传递体体外透皮释药研究
6) dissolution rate
释放度
1.
Determination of dissolution rate of levodropropizine sustained-release tablets;
左羟丙哌嗪缓释片体外释放度测定
2.
The comparison of dissolution rates of diclofenac sodium slow-released capsules;
双氯芬酸钠缓释胶囊体外释放度考察
3.
RESULTS The dissolution rate is decreased as hydroxypropylmethylcellulose(HPMC) increasing;Lactose and dextrin is good for preparing nimodipine sustained-release tablets;CONCLUSION No great difference in dissolution behavior is observed between market nimodipine sustained-release tablets and trial-products.
方法通过比较体外释放度筛选处方。
补充资料：促甲状腺素释放激素、促甲释放素
分子式：
CAS号：
性质：又称促甲状腺素释放激素、促甲释放素。为简单的三肽。易溶于无水甲醇，略溶于氯仿，不溶于吡啶。为下丘脑分泌的多肽激素。促进垂体生成促甲状腺素，同时还能刺激垂体释放泌乳素。可影响细胞钙库，增加Ca2+浓度而发挥作用；且有抗内毒素性休克作用。用于诊断甲状腺功能，判定甲状腺功能亢进复发趋势。也可治疗甲状腺机能减退和甲状腺癌患者。制剂为注射剂。
CAS号：
性质：又称促甲状腺素释放激素、促甲释放素。为简单的三肽。易溶于无水甲醇，略溶于氯仿，不溶于吡啶。为下丘脑分泌的多肽激素。促进垂体生成促甲状腺素，同时还能刺激垂体释放泌乳素。可影响细胞钙库，增加Ca2+浓度而发挥作用；且有抗内毒素性休克作用。用于诊断甲状腺功能，判定甲状腺功能亢进复发趋势。也可治疗甲状腺机能减退和甲状腺癌患者。制剂为注射剂。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条